ExactAb™,低内毒素,已验证,无动物源,无叠氮钠,无载体,重组 级 提供 ≥95%(SDS-PAGE&SEC-HPLC) 纯度，适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存,避免反复冻融。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Galcanezumab (anti-CALCA)是一种针对CGRP配体的人源化IgG4单克隆抗体。Galcanezumab (anti-CALCA)可用于偏头痛或丛集性头痛的研究。
Galcanezumab (anti-CALCA) is a humanized IgG4 monoclonal antibody against the CGRP ligand. Galcanezumab (anti-CALCA) can be used for migraine or cluster headaches research.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg
Galcanezumab (anti-CALCA) (Ab170931) - Flow Cytometry
Flow Cytometry analysis of A549 cells labelling CALCA (red) with Galcanezumab (anti-CALCA) (Ab170931). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Galcanezumab (anti-CALCA) (Ab170931) - Flow Cytometry
Flow Cytometry analysis of HeLa cells labelling CALCA (red) with Galcanezumab (anti-CALCA) (Ab170931). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Galcanezumab (anti-CALCA) (Ab170931) - SEC
The purity of Galcanezumab (anti-CALCA) (Ab170931) is more than 95% verified by HPLC.
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
 ZJ24F1012715 |
分析证书 | Ab170931 |
| ZJ24F1012716 |
分析证书 | Ab170931 |
| ZJ24F1012717 |
分析证书 | Ab170931 |
| ZJ24F0303727 |
分析证书 | Ab170931 |
| ZJ24F0303728 |
分析证书 | Ab170931 |
| ZJ24F0303729 |
分析证书 | Ab170931 |
我们的级别选择指南涵盖了目录中所有的变体的纯度、稳定剂状态和应用适用性。
查看 Animal Free 级别指南 → 查看 Carrier Free 级别指南 → 查看 Recombinant 级别指南 → 查看 Validated 级别指南 → 查看 ExactAb™ 级别指南 → 查看 Low Endotoxin 级别指南 → 查看 Azide Free 级别指南 →
危险品化学品经营许可证（带存储）